R03AL02 - salbutamol and ipratropium bromide : Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
C09DA01 - losartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
A02BC01 - omeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC01 - omeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
R03AK06 - salmeterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
C09DB06 - losartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
J01CR02 - amoxicillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
C08CA04 - nicardipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
R03DC53 - montelukast, combinations : Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.
J01DE51 - cefepime and beta-lactamase inhibitor : Belongs to the class of fourth generation cephalosporins. Used in the systemic treatment of infections.
A05BA03, A11HA03 - silymarin, tocopherol (vit E) : Belongs to the class of drugs used in liver therapy., Belongs to the class of other plain vitamin preparations. Used as dietary supplements.
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
J01CR05 - piperacillin and beta-lactamase inhibitor : Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
R03AL02 - salbutamol and ipratropium bromide : Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
C09DA01 - losartan and diuretics : Belongs to the class of angiotensin II receptor blockers (ARBs) in combination with diuretics. Used in the treatment of cardiovascular disease.
A02BC01 - omeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC01 - omeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
R03AK06 - salmeterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
C09DB06 - losartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.